24th Annual Summer Seminars: Psychopharmacology, 2013
Ross J. Baldessarini, MD, MA (hon.), D. Sc. (hon)
This seminar will address the clinically important science of psychopharmacology as applied to the treatment of schizophrenia, bipolar disorder, major depression, and anxiety disorders, including pharmacological principles, results of controlled clinical trials, and aspects of clinical applications of psychotropic agents that are important for optimal applications by practicing clinicians. The seminar will emphasize selected aspects of the evidence base underlying clinical practice in the use of psychotropic medicines to treat major psychiatric disorders, considering short-term and long term efficacy and dosing of antipsychotic, mood-stabilizing, antidepressant and antianxiety drugs as well as their adverseeffect risks. The seminar will also address the art of clinically successful and safe prescribing, and consider critically the limits of psychopharmacological approaches to the treatment of complex human problems.
• Improve understanding of the evidence supporting short-term
and long-term treatment of patients with psychotic, bipolar,
major depressive, and anxiety disorders;
• Improve psychotherapeutic drug treatment practices by greater
and more critical understanding of recent advances and
practical prescribing information;
• Accurately describe current relationships between treatment
with psychotropic drugs and risk of mortality due to suicide
and other causes;
• Better integrate psychopharmacology into comprehensive care
of psychiatric patients;
• More critically assess the advantages and limitations of
Warning: Invalid argument supplied for foreach() in /nfs/c10/h13/mnt/150145/domains/continuingeducationprogram.org/html/wp-content/themes/bidmc/single-courses.php on line 110
Friday: 4:30 – 6:30 pm
Saturday & Sunday: 8:15 am – 12:30 pm
Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 10
Physicians: The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Harvard Medical School designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Weekend Seminar: A maximum of 10 AMA PRA Category 1 Credits™
Psychologists: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is approved by the American Psychological Association to offer continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School maintains responsibility for this program and its content.
Counselors: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School continuing education is an NBCC Approved Continuing Provider (ACEP) and may offer NBCC approved clock hours for events that meet NBCC requirements. The Weekend Summer Seminars for a maximum of 10 clock hours. The ACEP solely is responsible for all aspects of the program.
Social Workers: For information on the status of the application to the Massachusetts Chapter of the National Association of Social Workers, please call 617-754-1265 or email: firstname.lastname@example.org.
Nurses: Beth Israel Deaconess Medical Center Nursing Education is an approved provider of continuing nursing education by
the Massachusetts Association of Registered Nurses, Inc., an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Beth Israel Deaconess Medical Center Nursing Education will provide contact hours for the following courses only:
Psychopharmacology, 2013, July 5-7, 2013, Harbor View Hotel and Resort, Martha’s Vineyard, MA;
Essential Psychopharmacology, 2013: Practice and Update, July 29-August 2, 2013, Sea Crest Beach Hotel, N. Falmouth, MA;
The Treatment of Major Depression and Anxiety Disorders: Integrating Psychopharmacology and Psychotherapeutic Strategies in Clinical Practice, August 5-9, 2013, Sea Crest Beach Hotel, N. Falmouth, MA;
Essential Psychopharmacology, 2013, August 26-30, 2013, Harvard View Hotel and Resort, Martha’s Vineyard, MA. All other summer programs meet the specifications of the Board of Registration in Nursing (244 CMR).
Ross J. Baldessarini, MD, MA (hon.), D. Sc. (hon) is a Professor of Psychiatry and in Neuroscience at Harvard Medical School and Director of the Psychopharmacology Program and International Consortium for Bipolar Disorder Research at McLean Hospital. Dr. Baldessarini is the recipient of many regional, national, and international research, mentoring, and teaching awards, and is on the Institute of Scientific Information list of most-cited authors in pharmacology and psychiatry. He has authored nearly 2100 scientific papers and several books, including Chemotherapy in Psychiatry, third edition. He also wrote the chapters on psychopharmacology for the standard American textbook of pharmacology, Goodman and Gilman’s Pharmacologic Basis of Therapeutics for several decades, and serves on editorial boards of leading journals in pharmacology and psychiatry